| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.3 | 2e-07 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.23 | 6e-07 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.13 | 0.009 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | -0.11 | 0.02 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | -0.11 | 0.03 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | -0.11 | 0.03 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | 0.087 | 0.05 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | 0.093 | 0.06 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | -0.062 | 0.2 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.056 | 0.2 |